Literature DB >> 2150174

Effect of celiprolol on large and small arteries of the forearm circulation in hypertensive patients.

O Roman1, N Meza, C Klenner.   

Abstract

Celiprolol, a new highly cardioselective beta blocker, also has direct vasodilating properties. Since the noninvasive echo Doppler technique applied to the forearm circulation (brachial artery) allows the differentiation of arteriolar vasodilation (revealed by the increasing arterial blood flow velocity) from vasodilation of large arteries (shown by an increase in arterial diameter), it seems important to study the site of celiprolol's vasodilating effect. Thirty-five hypertensive patients, (21 male, 14 female; mean age, 59 +/- 11, range 42-79 years) were treated with increasing doses of celiprolol, 200 and 400 mg, over 15 days. The duplex echo Doppler technique (Aloka 7.5 M Hz probe) was used before and during each celiprolol dose period. Statistical analysis was performed by Student's paired t test. It was observed that celiprolol significantly increases the brachial artery diameter in a dose-dependent manner, and also increases the blood flow velocity (not being direct dose-related). Since the increase in diameter was clear with a higher dose, a dose-dependent increase in blood volume, a decrease in peripheral resistance, and an increase in compliance followed. Since the higher dose of celiprolol did not further reduce blood pressure (BP) in comparison to the lower dose, and a dose-dependent increase in arterial diameter and compliance occurred and a vasodilating effect of celiprolol on arterial wall ensued that was not related to BP. In conclusion, in the doses used, celiprolol dilates both arterioles and large arteries, but the mechanism of action needs to be clarified.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2150174     DOI: 10.1007/bf01856564

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  17 in total

1.  Comparative effects of propranolol and pindolol on small and large arteries and veins of the forearm circulation in hypertensive man.

Authors:  B L Maarek; J A Bouthier; A C Simon; J A Levenson; M E Safar
Journal:  J Cardiovasc Pharmacol       Date:  1986       Impact factor: 3.105

2.  Chronic effects of pindolol on the arterioles, large arteries, and veins of the forearm in mild to moderate essential hypertension.

Authors:  B Maarek; A C Simon; J Levenson; I Merli; J Bouthier
Journal:  Clin Pharmacol Ther       Date:  1986-04       Impact factor: 6.875

3.  Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension.

Authors:  L Hansson; A J Zweifler; S Julius; S N Hunyor
Journal:  Acta Med Scand       Date:  1974 Jul-Aug

Review 4.  Hemodynamic and vascular responses to antihypertensive treatment with adrenergic blocking agents: a review.

Authors:  R Sannerstedt; J Conway
Journal:  Am Heart J       Date:  1970-01       Impact factor: 4.749

5.  Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man.

Authors:  M Ulrych; E D Frohlich; H P Dustan; I H Page
Journal:  Circulation       Date:  1968-03       Impact factor: 29.690

6.  Celiprolol: pharmacokinetics and duration of pharmacodynamic activity.

Authors:  F S Caruso; H D Doshan; P H Hernandez; R Costello; W Applin; E S Neiss
Journal:  Br J Clin Pract Suppl       Date:  1985-06

7.  Pulsed Doppler: diameter, blood flow velocity and volumic flow of the brachial artery in sustained essential hypertension.

Authors:  M E Safar; P A Peronneau; J A Levenson; J A Toto-Moukouo; A C Simon
Journal:  Circulation       Date:  1981-02       Impact factor: 29.690

8.  Effect of acebutolol on left ventricular hemodynamics and anatomy in systemic hypertension.

Authors:  B Trimarco; B Ricciardelli; N De Luca; M Volpe; A Veniero; A Cuocolo; M Condorelli
Journal:  Am J Cardiol       Date:  1984-03-01       Impact factor: 2.778

9.  Effects of celiprolol on systemic and forearm circulation in hypertensive patients: a double-blind cross-over study versus metoprolol.

Authors:  B Trimarco; G Lembo; N De Luca; B Ricciardelli; G Rosiello; M Volpe; G Orofino; M Condorelli
Journal:  J Clin Pharmacol       Date:  1987-08       Impact factor: 3.126

10.  Structural changes of large arteries in sustained essential hypertension.

Authors:  M E Safar; A C Simon; J A Levenson
Journal:  Hypertension       Date:  1984 Nov-Dec       Impact factor: 10.190

View more
  5 in total

Review 1.  Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease.

Authors:  R J Milne; M M Buckley
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

2.  Effect of pretreatment with the selective beta 1-adrenoceptor antagonist bisoprolol on the subsequent cardiovascular actions and beta-adrenoceptor subtype specific occupancy of celiprolol in healthy man.

Authors:  C de Mey; K Beithaupt; D Palm; U Fuhr; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 3.  Celiprolol. An evaluation of its pharmacological properties and clinical efficacy in the management of hypertension and angina pectoris.

Authors:  C J Dunn; C M Spencer
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923

Review 4.  A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease.

Authors:  M J Kendall; I Rajman
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

5.  Celiprolol: A Unique Selective Adrenoceptor Modulator.

Authors:  James J Nawarskas; Angela Cheng-Lai; William H Frishman
Journal:  Cardiol Rev       Date:  2017 Sep/Oct       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.